Ptc Therapeutics (PTCT) Acquisitions (2017 - 2018)
Ptc Therapeutics (PTCT) recorded quarterly Acquisitions of $48.9 million in Q3 2018, up 163.97% quarter-over-quarter from -$76.4 million in Q3 2017, and up 163.97% on a YoY basis from $18.5 million in Q3 2017.
Ptc Therapeutics (PTCT) Acquisitions (2017 - 2018) Analysis & Trends
Ptc Therapeutics' Acquisitions history runs 2 years deep, the most recent figure standing at $48.9 million for Q3 2018.
- In Q3 2018, Acquisitions rose 163.97% year-over-year to $48.9 million; the TTM figure through Dec 2019 stood at $48.9 million (up 277.58% YoY), while the FY2018 annual figure was $48.9 million, changed N/A from the prior year.
- Acquisitions was $48.9 million for Q3 2018 at Ptc Therapeutics, up from -$76.4 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $48.9 million in Q3 2018 to a low of -$76.4 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 48.89 Mn |
| Sep 30, 2017 | -76.42 Mn |